川崎病冠脉损害的干细胞治疗研究进展
Research Progress of Stem Cell Therapy for Coronary Artery Damage in Kawasaki Disease
DOI: 10.12677/ACM.2021.112117, PDF,   
作者: 万 萱, 冯建英, 严晓华, 张西嫔, 王菊艳, 李晓红, 李思琼, 焦富勇*：陕西省人民医院儿童病院，陕西 西安；成 钧：西北妇女儿童医院儿科，陕西 西安；肖 成：西安北车医院儿科，陕西 西安
关键词: 川崎病；冠脉损害；干细胞；Kawasaki Disease； Coronary Artery Lesion； Stem Cell
摘要: 川崎病是一种具有明显季节性和区域流行性的疾病，好发于5岁以下儿童，表现为急性自限性的全身性血管炎，累及中小动脉，特别是冠状动脉病变。目前发病呈增高趋势，大约15%~25%未经系统治疗的儿童最终发展成冠状动脉损害，成为发达国家儿童获得性心脏病的最常见原因。目前干细胞治疗小鼠川崎病模型所致的冠脉损害取得重要进展，现就干细胞治疗川崎病冠脉损害的形成进行简要综述。
Abstract: Kawasaki Disease (KD) is an acute, self-limited systemic vasculitis that affects the middle and small arteries, especially the coronary arteries. The incidence is currently on the rise, with about 15 to 25 per cent of children without systemic disease eventually developed coronary artery damage, becoming the most common cause of child-acquired heart disease in the countries where it occurs. At present, stem cell therapy for Kawasaki Disease in mice has made important progress. This article reviews the formation of stem cell therapy for Kawasaki disease.
文章引用：万萱, 冯建英, 严晓华, 张西嫔, 王菊艳, 李晓红, 李思琼, 成钧, 肖成, 焦富勇. 川崎病冠脉损害的干细胞治疗研究进展[J]. 临床医学进展, 2021, 11(2): 826-830. https://doi.org/10.12677/ACM.2021.112117

参考文献

[1] Newburger, J.W., Takahashi, M. and Burns, J.C. (2016) Kawasaki Disease. Journal of the American College of Cardiology, 67, 1738-1749.
[Google Scholar] [CrossRef] [PubMed]
[2] Magali, N.R. and Moshe, A. (2020) Kawasaki Disease: Pathophysiology and Insights from Mouse Models. Nature Reviews Rheumatology, 16, 391-405.
[Google Scholar] [CrossRef] [PubMed]
[3] Jiao, F.Y., Yan, X.H. and Wu, X.F. (2016) The Xi’an Experience of Kawasaki Disease—Lessons Learnt over 5 Years. The Indian Journal of Pediatrics, 83, 1195-1196.
[Google Scholar] [CrossRef] [PubMed]
[4] Yokota, S., Kikuchi, M., Nozawa, T., et al. (2015) Pathogenesis of Systemic Inflammatory Disease in Childhood: Lessons from Clinical Trials of Anti-Cytokine Monoclonal Antibodies for Kawasaki Disease, Systemic Onset Juvenile Idiopathic Arthritis and Cryopyrin-Associated Periodic Fever Syndrome. Modern Rheumatology, 25, 1-10.
[Google Scholar] [CrossRef] [PubMed]
[5] Jiao, F.Y., Wang, J.Y., Feng, Y.J., Zhang, S., He, G.T. and Li, X.H. (2020) Clinical Analysis of Occurrence of Coronary Artery Aneurysm in 426 Children with Kawasaki Disease. Annals of Pediatric Research, 4, 6-8.
[6] 叶贝. 川崎病病因及发病机制的研究进展[J]. 儿科药学杂志, 2012, 18(4): 49-52.
[7] 饶晓红, 童文娟, 陈丁丁. 川崎病并发感染患儿Treg/Th17细胞免疫功能的变化及临床意义[J]. 中国医药导报, 2020, 17(5): 91-94.
[8] 刘亮, 田执梁. 川崎病相关易感基因研究进展[J]. 中国生育健康杂志, 2021, 32(1): 98-101.
[9] Lehman, T.J., Allen, J.B., Plotz, P.H., et al. (1983) Polyarthritis in Rats Following the Systemic Injection of Lactobacillus casei Cell Walls in Aqueous Suspension. Arthritis & Rheumatology, 26, 1259-1265.
[Google Scholar] [CrossRef] [PubMed]
[10] Lehman, T.J., Walker, S.M., Mahnovski, V., et al. (1985) Coronary Arteritis in Mice Following the Systemic Injection of Group B Lactobacillus casei Cell Walls in Aqueous Suspension. Arthritis & Rheumatology, 28, 652-659.
[Google Scholar] [CrossRef] [PubMed]
[11] Philip, S., Lee, W., Liu, S., et al. (2004) A Swine Model of Horse Serum-Induced Coronary Vasculitis: An Implication for Kawasaki Disease. Pediatric Research, 55, 211-219.
[Google Scholar] [CrossRef] 
[12] Yan, W., Abu-El-Rub, E., Saravanan, S., et al. (2019) Inflammation in Myocardial Injury: Mesenchymal Stem Cells as Potential Immunomodulators. American Journal of Physiology—Heart and Circulatory Physiology, 317, H213-H225.
[Google Scholar] [CrossRef] [PubMed]
[13] Yap, J., Cabrera-Fuentes, H.A., Irei, J., et al. (2019) Role of Macrophages in Cardioprotection. International Journal of Molecular Sciences, 20, 2472.
[Google Scholar] [CrossRef] [PubMed]
[14] Peng, Y., Chen, B.Q., Zhao, J.L., et al. (2019) Effect of Intravenous Transplantation of hUCB-MSCs on M1/M2 Subtype Conversion in Monocyte/Macrophages of AMI Mice. Biomedicine & Pharmacotherapy, 11, 624-630.
[Google Scholar] [CrossRef] [PubMed]
[15] Peng, Y., Pan, W., Ou, Y., et al. (2016) Extracardiac-Lodged Mesenchymal Stromal Cells Propel an Inflammatory Response against Myocardial Infarction via Paracrine Effects. Cell Transplantation, 25, 929-935.
[Google Scholar] [CrossRef] 
[16] Xu, R., Zhang, F., Liu, N., et al. (2019) Exosomes Derived from Pro-Inflammatory Bone Marrow-Derived Mesenchymal Stem Cells Reduce Inflammation and Myocardial Injury via Mediating Macrophage Polarization. Journal of Cellular and Molecular Medicine, 23, 7617-7631.
[Google Scholar] [CrossRef] [PubMed]
[17] Hirai, K., et al. (2020) Cardiosphere-Derived Exosomal microRNAs for Myocardial Repair in Pediatric Dilated Cardiomyopathy. Science Translational Medicine, 12, eabb3336.
[Google Scholar] [CrossRef] [PubMed]
[18] 袁肇凯, 黄献平, 李勇华, 等. 养心通脉有效部位方动员骨髓间充质干细胞归巢大鼠心肌梗塞的实验研究[J]. 中华中医药杂志, 2012, 23(1): 115-118.
[19] Chartrel, N., Alonzeau, J., Alexadre, D., et al. (2011) The RF Amide Neuropeptide 26RFa and Its Role in the Control of Neuroendocrine Function. Frontiers in Neuroendocrinology, 32, 387-397.
[Google Scholar] [CrossRef] [PubMed]
[20] Ukena, K., Tachibana, T., Iwakoshi-Ukena, E., et al. (2010) Identification, Localization, and Function of a Novel Avian Hypothalamic Neuropeptide 26RFa and Its Cognate Receptor, G-Protein-Coupled Rece-103. Endocrinology, 151, 2255-2264.
[Google Scholar] [CrossRef] [PubMed]
[21] Zhao, L., Liu, L., Wu, Z., et al. (2012) Effects of Micropitted/Nanotubular Titania Topographies on Bone Mesenchymal Stem Cell Osteogenic Differentiation. Biomaterials, 33, 2629-2642.
[Google Scholar] [CrossRef] [PubMed]
[22] Zheng, J., Wan, Y., Chi, J., et al. (2012) The Active Principle Region of Buyang Huanwu Decoction Induced Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells into Neural-Like Cells: Superior Effects over Original Formula of Buyang Huanwu Decoction. Neural Regeneration Research, 7, 261-267.
[23] 郑景辉, 李勇华, 王丽萍, 等. 不同血清微环境对大鼠骨髓间充质干细胞体外培养的影响[J]. 中国组织工程研究与临床康复, 2010, 14(14): 2497-2502.

为你推荐